OGT launches SureSeq™ Myeloid Plus panel and Universal NGS Complete Workflow
Sysmex and JCR Pharmaceuticals Establish a Joint Venture in the Field of Regenerative Medicine and Cell Therapy
Pilot, Inc. Becomes Wholly-owned Sysmex Subsidiary Through the Acquisition of Outstanding Shares
Bayerische Hausbau and MATRIX lay the foundation stone for the new work campus FLOW in Hamburg
The Ajinomoto Foundation, Sysmex, and NEC initiate a cross-industry co-creation project to improve maternal and child health and nutrition in the Republic of Ghana
Sysmex Establishes Subsidiary in Saudi Arabia
Sysmex R&D Center Europe and “academist” begin collaborating in providing academic research funds in Europe
Discover the fighter in you – through our latest antimicrobial resistance (AMR) awareness campaign!
Die neue Ausgabe unseres Kundenmagazins xtra ist da!
Sysmex Europe wins awards in the programme ‘Excellence in learning 2021’ by Brandon Hall Group
Patient stratification and prognostic scores – the value of routine diagnostic parameters in supporting COVID-19 disease management
Sysmex EMEA’s first virtual congress, Sysmex Expo 2020 – a great success!
Sysmex Launches Surgical Robot Unit, hinotoriTM Surgical Robot System
"Conquering the wave" – preparing for the second wave of COVID-19
Sysmex Europe is celebrating 40 years of diagnostic advancement and growth
Sysmex Obtains First Marketing Approval in Japan for the Novel Coronavirus Nucleic Acid Detection Kits (RT-PCR Method)
-Japanese market only-